Nevertheless, aCL, IgM and IgG were also associated with ILD, with aCL IgG emerging as a potential biomarker of ILD with concomitant PH (PH-ILD, group 3) (OR 2.10, 95% CI, 1.05–4.20). The gene discussed is ACLY; the disease is interstitial lung disease.